“pfizer-venture-investments” Archives

Entry Author Date Location
AnTolRx Secures $4,000,000 Series A Funding Round 09/09/16 Boston
Second Genome Replaces DiLaura as CEO, Brings Series B to $51M 07/13/16 San Francisco
Morphic Therapeutic Garners $51,500,000 Series A Funding 06/30/16 Boston
Blade Therapeutics Garners $45,000,000 Series B Funding 06/20/16 San Francisco
Second Genome Lands $42,600,000 Series B Financing Round 04/20/16 San Francisco
Imara Lands $31,000,000 Series A Round 04/15/16 San Francisco
Cydan, NEA’s Orphan Drug Accelerator, Targets Sickle Cell With Startup Imara 04/14/16 Boston
RefleXion Medical Obtains $46,000,000 Series B Round 04/14/16 San Francisco
Biodesy Receives $10,000,000 Series B Round 01/25/16 San Francisco
Lodo Therapeutics Obtains $17,000,000 Series A Funding 01/13/16 New York
Accelerator, Gates Team Up in NY to Put $17M Into Rockefeller Startup 01/10/16 New York
Petra Pharma Receives $48,000,000 Series A Financing Round 01/07/16 New York
NextCure Receives $67,000,000 Series A Financing 01/07/16 Boston
RaNA CEO Renaud Turns To A Former Backer To Lead $55M Series B 07/23/15 Boston
RaNA Therapeutics Receives $55,000,000 Series B Funding Round 07/23/15 Boston
Epic Sciences Raises $30M to Advance Cancer Diagnostics 07/30/14 San Diego
Accelerator Bags $51M, Makes Long-Awaited Move to NYC 07/29/14 New York
MoneyTree Reports $35.6M in MI Venture Deals Last Quarter 04/18/14 Detroit Ann Arbor
Epic Sciences Compiling Data on Ultra-Sensitive Cancer Diagnostic 01/29/14 San Diego
Biodesy Garners $15,000,000 Series A Financing Round 10/18/13 San Francisco
East Coast Life Sciences Roundup: Moderna, Inotek, Roche, & More 10/04/13 Boston
Cydan, the NEA Startup Machine, Scours the Globe for Orphan Drugs 04/25/13 Boston
Cydan Receives $16,000,000 New Financing Round 04/12/13 Boston
Flexion Therapeutics Obtains $20,000,000 Series B Funding 12/04/12 Boston
Pfizer Invests in Rhythm to Support Diabetes, Obesity Drug Programs 11/27/12 Boston
Rhythm Pharmaceuticals Obtains $8,000,000 Series B Round 11/27/12 Boston
San Diego Life Sciences Roundup: Allergan, Qualcomm Life, & More 11/21/12 San Diego
Epic Sciences Raises $13M, Advances Ultra-Sensitive Cell Diagnostics 11/13/12 San Diego
Epic Sciences Secures $13,000,000 Series B Financing Round 11/13/12 San Diego
Mirna Therapeutics Secures $34,500,000 Series C Funding Round 10/24/12 Texas
Page 1 of 2 next page »